SCHEMBL10128237

SCHEMBL10128237

CC(C)S(=O)(=O)c1ccccc1Nc1nc(NC2CCCNC2)[nH]c(=O)c1C(N)=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 1/20 0.42
CDK9 P50750 13/20 0.42
CDK7 P50613 13/20 0.42
HTR6 P50406 2/20 0.40
CCNH P51946 1/20 0.40
MNAT1 P51948 1/20 0.40
AURKA O14965 1/20 0.40
NTRK1 P04629 1/20 0.40
IGF1R P08069 1/20 0.40
CDK4 P11802 1/20 0.40
EPHA1 P21709 1/20 0.40
CDK2 P24941 1/20 0.40
CDK3 Q00526 1/20 0.40
CDK6 Q00534 1/20 0.40
CDK5 Q00535 1/20 0.40
SYK P43405 2/20 0.40
ALK Q9UM73 1/20 0.38
MAPK3 P27361 1/20 0.38
MAPK1 P28482 1/20 0.38
KCNH2 Q12809 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL282838 0.99 IRAK4 (0.42) IRAK4CDK9CDK7HTR6CCNH
SCHEMBL10128158 0.86 CDK9 (0.49) CDK9CDK7AURKANTRK1IGF1R
SCHEMBL10128168 0.86 CDK9 (0.56) CDK9CDK7AURKANTRK1IGF1R
SCHEMBL10128165 0.86 CDK9 (0.56) CDK9CDK7AURKANTRK1IGF1R
SCHEMBL10128186 0.86 CDK9 (0.45) CDK9CDK7AURKANTRK1IGF1R
SCHEMBL10128236 0.84 MAPK3 (0.41) CDK9CDK7AURKANTRK1IGF1R
SCHEMBL282258 0.84 CDK9 (0.44) CDK9CDK7AURKANTRK1IGF1R
SCHEMBL10128201 0.84 SYK (0.55) CDK9CDK7AURKANTRK1IGF1R
SCHEMBL10128187 0.84 SYK (0.45) CDK9CDK7AURKANTRK1IGF1R
SCHEMBL10128154 0.84 SYK (0.47) CDK9CDK7AURKANTRK1IGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9487491-B2 Diamino heterocyclic carboxamide compound ASTELLAS PHARMA INC. (JP) 2016-11-08 US disclosed
US-8969336-B2 Diamino heterocyclic carboxamide compound ASTELLAS PHARMA INC. (JP) 2015-03-03 US disclosed
US-20140371196-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND ASTELLAS PHARMA INC. (JP) 2014-12-18 US disclosed
US-20120040968-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND WATERS TECHNOLOGIES CORPORATION (US) 2012-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140371196-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND EML4, ALK, ERBB4 IRAK4 403/4885CDK9 293/4885CDK7 952/4885
US-20120040968-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND EML4, ALK, ERBB4 IRAK4 403/4885CDK9 293/4885CDK7 952/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.